multiple sclerosis

The Long Tail of a Clinical Trial

May 2, 2011

To conduct a clinical trial of a new drug, the researchers need to pick an ending: a place where the experiment will be stopped and the results between those taking the drug and those who haven’t can be compared. If the drug is a clear [Read more]

The MS Cases That Aren’t

November 29, 2010

Doctors classify diseases like zoologists classify animals. A new disease, discovered and described, is placed next to diseases with similar symptoms, causes, and prognosis, which helps inform physicians about the best treatments to initially try. [Read more]

From Wasp Fungus to New MS Drug

September 22, 2010

Just twenty years ago, there were no therapies available for the management of multiple sclerosis. Physicians could give patients drugs to try and blunt the damage caused by the disease’s intermittent attacks on the central nervous system, but [Read more]

The Mouse With Sleeper Toxins

September 20, 2010

Studying a disease using an animal model is not as simple as merely replicating it. For instance, a variety of techniques have been used in animals to simulate the neurological disorder multiple sclerosis, where the protective myelin sheath that [Read more]

From the Rain Forest to the Laboratory

May 18, 2010

Venomous animals such as snakes, scorpions and spiders are typically the stuff of phobias for most people. But the toxins those creatures have developed to immobilize and kill their prey are actually some of nature’s most finely-tuned weapons, [Read more]